Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Higgins John L
Relationship:   Director
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   2,806,928    

Indirect Shares

   0      
Direct Value   $48,656,136    

Indirect Value

   $0      
Total Shares   2,806,928      
Total Value   $48,656,136      


Ligand Pharmaceuticals Inc $35,115,619 Techne Corp $3,000,758 OmniAb, Inc $10,539,760 Ligand Pharmaceuticals Inc $35,115,619 Techne Corp $3,000,758 OmniAb, Inc $10,539,760
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    10    

     Stock price went up :
    0   
    5    
     Stock price went down :
    0   
    5    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
 -30.2%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Ligand Pharmaceuticals Inc LGND Director 2022-12-28 417,695 2007-02-01 0    Premium*  
            Techne Corp TECH Director 2023-10-26 36,608 2013-10-31 0    Premium*  
            OmniAb, Inc OABI Director 2024-01-30 2,352,625 2022-11-01 0    Premium*  
* Premium Members only  

Records found :    163         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
LGND Ligand Pharmaceuticals In... CEO & President   •       –      –    2007-02-01 4 A $12.68 $1,902,000 D/D 150,000 150,000 0 -
LGND Ligand Pharmaceuticals In... President & CEO   •       •      –    2007-06-15 4 B $6.70 $13,400 D/D 2,000 152,000 2.81 -
LGND Ligand Pharmaceuticals In... President & CEO   •       •      –    2007-08-13 4 B $5.86 $11,720 D/D 2,000 154,000 2.81 -
LGND Ligand Pharmaceuticals In... President & CEO   •       •      –    2008-02-23 4 A $0.00 $0 D/D 28,000 257,000 0 -
LGND Ligand Pharmaceuticals In... President & CEO   •       •      –    2008-02-23 4 A $0.00 $0 D/D 75,000 229,000 0 -
LGND Ligand Pharmaceuticals In... President & CEO   •       •      –    2009-02-15 4 A $0.00 $0 D/D 75,000 332,000 0 -
LGND Ligand Pharmaceuticals In... President & CEO   •       •      –    2009-02-15 4 A $0.00 $0 D/D 24,000 356,000 0 -
LGND Ligand Pharmaceuticals In... President & CEO   •       •      –    2009-12-31 4 A $1.84 $2,099 D/D 1,138 333,138 0 -
LGND Ligand Pharmaceuticals In... President & CEO   •       •      –    2010-02-15 4 A $0.00 $0 D/D 75,000 433,276 0 -
LGND Ligand Pharmaceuticals In... President & CEO   •       •      –    2010-02-17 4 B $1.67 $10,020 D/D 6,000 439,276 2.81 -
LGND Ligand Pharmaceuticals In... President & CEO   •       •      –    2010-06-30 4 A $1.24 $2,100 D/D 1,692 440,968 0 -
LGND Ligand Pharmaceuticals In... President & CEO   •       •      –    2010-12-31 4 A $7.14 $2,099 D/D 294 73,788 0 -
LGND Ligand Pharmaceuticals In... President & CEO   •       •      –    2011-02-17 4 A $0.00 $0 D/D 15,000 88,494 0 -
LGND Ligand Pharmaceuticals In... President & CEO   •       •      –    2011-06-30 4 A $7.64 $2,116 D/D 277 89,065 0 -
LGND Ligand Pharmaceuticals In... President & CEO   •       •      –    2011-12-30 4 A $10.09 $2,119 D/D 210 89,275 0 -
LGND Ligand Pharmaceuticals In... President & CEO   •       •      –    2012-02-09 4/A A $0.00 $0 D/D 6,000 95,275 0 -
LGND Ligand Pharmaceuticals In... President & CEO   •       •      –    2012-05-04 4 B $12.04 $12,040 D/D 1,000 108,275 2.81 -
LGND Ligand Pharmaceuticals In... President & CEO   •       •      –    2012-06-29 4 A $10.12 $12,654 D/D 1,250 109,525 0 -
LGND Ligand Pharmaceuticals In... President & CEO   •       •      –    2012-08-13 4 B $16.39 $8,195 D/D 500 110,025 2.81 -
LGND Ligand Pharmaceuticals In... President & CEO   •       •      –    2012-12-05 4 B $18.03 $36,060 D/D 2,000 112,025 2.81 -
LGND Ligand Pharmaceuticals In... President & CEO   •       •      –    2013-02-15 4 A $0.00 $0 D/D 8,000 120,025 0 -
LGND Ligand Pharmaceuticals In... President & CEO   •       •      –    2013-06-03 4 A $0.00 $0 D/D 12,000 120,025 0 -
LGND Ligand Pharmaceuticals In... President & CEO   •       •      –    2013-08-16 4 S $42.85 $428,500 D/D (10,000) 110,025 0 -
LGND Ligand Pharmaceuticals In... President & CEO   •       •      –    2013-08-19 4 OE $16.14 $105,814 D/D 6,556 116,581 0 -
LGND Ligand Pharmaceuticals In... President & CEO   •       •      –    2013-10-18 4 AS $55.00 $550,000 D/D (10,000) 106,581 0 -
  163  Records found
  1  2   3   4   5   6   7      
  Page 1 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us